Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria
Jun‐ichi Nishimura, Kiyoshi Ando, Masayoshi Masuko, Hideyoshi Noji, Yoshikazu Ito, Jiří Mayer, Laimonas Griškevičius, Christoph Bucher, Florian Müllershausen, P Gergely, Izabela Rozenberg, Anna Schubart, Raghav Chawla, Jean‐Michel Rondeau, Michael Roguska, Igor Splawski, Mark T. Keating, Leslie Johnson, Rambabu Danekula, Morten Bagger, Yoko Watanabe, Börje Haraldsson, Yuzuru Kanakura
Abstract
Not available.
Topics & Concepts
Paroxysmal nocturnal hemoglobinuriaMedicineHemoglobinuriaInternal medicineDermatologyAnemiaComplement system in diseasesRenal Diseases and GlomerulopathiesCoagulation, Bradykinin, Polyphosphates, and Angioedema